A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes

NCT02119819 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2944876
DRUG: Exenatide extended-release
DRUG: Placebo
DRUG: Metformin

Sponsor

OPKO Health, Inc.